Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when TriSalus Life Sciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get TLSI alerts

About Steven Katz

TriSalus Life Sciences, Inc. reported in an 8-K filed August 16, 2023 that Steven Katz was appointed Chief Medical Officer, effective August 10, 2023. The proxy statement of TriSalus Life Sciences, Inc. reports total compensation of $1,613,005 for Steven Katz in fiscal 2023, including a base salary of $486,769. Disclosed compensation is on record for 2 fiscal years. TriSalus Life Sciences, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at TriSalus Life Sciences, Inc. includes Mary Szela (CEO and Board Member), Karim Karti (Chairman), Mats Wahlström (Chairman and Board Member) and 7 others.

“Immediately following Closing, the New TriSalus Board appointed the following individuals as the Company's executive officers: Mary Szela to serve as Chief Executive Officer and President, Sean Murphy to serve as Chief Financial Officer, James Alecxih to serve as President, Device Technology, Steven Katz to serve as Chief Medical Officer, Bryan Cox to serve as Chief Scientific and Manufacturing Officer, Jennifer Stevens to serve as Chief Regulatory Officer, and Richard Marshak to serve as Senior Vice President, Corporate Development & Strategy.”
TriSalus Life Sciences, Inc. Form 8-K, filed August 16, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at TriSalus Life Sciences, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 TriSalus Life Sciences, Inc. (TLSI) $486,769 $1,613,005
2022 TriSalus Life Sciences, Inc. (TLSI) $468,197 $799,146

Recent activity